Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS)
CNY 19.91
(1.01%)
CNY 19.91
(1.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.35 Billion | 1.17 Billion | 712.21 Million | 881.67 Million | 988.08 Million | 856.81 Million |
| Cost of Revenue | 1 Billion | 910.4 Million | 511.16 Million | 582.17 Million | 642.29 Million | 573.6 Million |
| Gross Profit | 348.75 Million | 269.15 Million | 201.05 Million | 299.49 Million | 345.79 Million | 283.2 Million |
| Operating Expenses | 211.78 Million | 168.8 Million | 143.34 Million | 164.66 Million | 143.69 Million | 136.04 Million |
| Selling, General and Administrative Expenses | 64.93 Million | 50.87 Million | 53.88 Million | 73.93 Million | 58.05 Million | 46.1 Million |
| Research and Development Expenses | 81.73 Million | 44.94 Million | 37.29 Million | 38.41 Million | 37.19 Million | 32.69 Million |
| Other Expenses | 65.11 Million | 72.97 Million | 52.17 Million | 52.3 Million | 48.45 Million | -4.42 Million |
| Cost and Expenses | 1.21 Billion | 1.07 Billion | 654.51 Million | 746.83 Million | 785.98 Million | 709.65 Million |
| Operating Income | 136.97 Million | 120.59 Million | 78.92 Million | 133.76 Million | 197.15 Million | 132.95 Million |
| Interest Expense | 3.59 Million | 842.78 Thousand | 218.79 Thousand | 656.91 Thousand | 3.33 Million | 7.52 Million |
| Income Tax Expense | 13.44 Million | 10.67 Million | 8.56 Million | 15.7 Million | 26.02 Million | 19.19 Million |
| Earnings before Tax | 134.69 Million | 115.09 Million | 77.06 Million | 130.18 Million | 194.35 Million | 128.52 Million |
| Net Income | 121.24 Million | 104.42 Million | 68.49 Million | 114.48 Million | 168.32 Million | 109.33 Million |
| Earnings Per Share Basic | 1.08 | 0.92 | 0.60 | 1.01 | 1.48 | 1.28 |
| Earnings Per Share Diluted | 0.97 | 0.92 | 0.60 | 1.01 | 1.48 | 1.28 |
| Weighted Average Shares Outstanding | 112.57 Million | 113.6 Million | 113.6 Million | 113.6 Million | 113.6 Million | 85.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 124.99 Million | 113.6 Million | 113.6 Million | 113.6 Million | 113.6 Million | 85.41 Million |
| Gross Margin | 0.26 | 0.23 | 0.28 | 0.34 | 0.35 | 0.33 |
| EBIT Margin | 0.19 | 0.18 | 0.21 | 0.22 | 0.27 | 0.23 |
| Profit Margin | 0.09 | 0.09 | 0.10 | 0.13 | 0.17 | 0.13 |
| EBITDA | 253.19 Million | 210.19 Million | 148.27 Million | 193.82 Million | 258.48 Million | 193.43 Million |
| Earnings Before Tax Margin | 0.10 | 0.10 | 0.11 | 0.15 | 0.20 | 0.16 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 310.69 Million | 293.39 Million | 352.58 Million | 1.35 Billion | 351.95 Million | 330.31 Million |
| Cost of Revenue | 222.31 Million | 224.44 Million | 263.02 Million | 995.09 Million | 253.06 Million | 231.53 Million |
| Gross Profit | 88.37 Million | 68.94 Million | 89.56 Million | 361.35 Million | 98.89 Million | 98.78 Million |
| Operating Expenses | 76.41 Million | 61.53 Million | 58.71 Million | 225.58 Million | 64.98 Million | 62.14 Million |
| Selling, General and Administrative Expenses | 51.82 Million | 37.01 Million | 43.32 Million | - | -43.42 Million | 79.43 Million |
| Research and Development Expenses | 23.61 Million | 22.42 Million | 19.28 Million | - | 28.13 Million | 22.93 Million |
| Other Expenses | -981.93 Thousand | -2.1 Million | -623.45 Thousand | -2.27 Million | 1.9 Million | -1.28 Million |
| Cost and Expenses | 298.73 Million | 285.98 Million | 321.74 Million | 1.22 Billion | 318.04 Million | 293.68 Million |
| Operating Income | 11.96 Million | 7.4 Million | 28.58 Million | 136.97 Million | 37.74 Million | 34.27 Million |
| Interest Expense | 1.19 Million | 567.64 Thousand | 711.8 Thousand | 3.59 Million | 973.65 Thousand | 1.04 Million |
| Income Tax Expense | 3.59 Million | 2.77 Million | 3.92 Million | 13.44 Million | 3.96 Million | 2.03 Million |
| Earnings before Tax | 16.28 Million | 11.2 Million | 27.96 Million | 134.69 Million | 39.65 Million | 32.98 Million |
| Net Income | 12.69 Million | 8.43 Million | 24.03 Million | 121.24 Million | 35.68 Million | 30.95 Million |
| Earnings Per Share Basic | 0.11 | 0.07 | 0.21 | - | 0.32 | 0.28 |
| Earnings Per Share Diluted | 0.09 | 0.06 | 0.16 | - | 0.26 | 0.23 |
| Weighted Average Shares Outstanding | 112.58 Million | 112.58 Million | 114.47 Million | 112.57 Million | 112.57 Million | 110.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 141.06 Million | 140.56 Million | 150.24 Million | 124.99 Million | 137.25 Million | 134.57 Million |
| Gross Margin | 0.28 | 0.23 | 0.25 | 0.27 | 0.28 | 0.30 |
| EBIT Margin | 0.06 | 0.14 | 0.10 | - | 0.12 | 0.12 |
| Profit Margin | 0.04 | 0.03 | 0.07 | 0.09 | 0.10 | 0.09 |
| EBITDA | 17.48 Million | 41.84 Million | 33.99 Million | - | 40.51 Million | 40.09 Million |
| Earnings Before Tax Margin | 0.04 | 0.03 | 0.08 | 0.10 | 0.11 | 0.10 |
300085
8897
KLSVF
6278
KKO
2769